Study of TYK-01054 Capsules in Patients With Advanced Solid Tumors

Clinical trial NCT07282873 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07282873
Sponsor: TYK Medicines, Inc
Status: NOT_YET_RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Solid Tumor Malignancies Malignant Mesothelioma (MM)

Start date: 2026-01-01
Primary completion: 2028-01-01
Enrollment: 219

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.